Publication Name	World Journal of Gastroenterology
Manuscript ID	7207
Country	Italy

Received	2013-11-09 08:54
Peer-Review Started	2013-11-09 21:56
To Make the First Decision	2013-12-26 11:27
Return for Revision	2014-04-03 17:15
Revised	2014-04-18 19:06
Second Decision	2014-05-19 11:04
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-05-19 11:16
Articles in Press	2014-05-23 09:56
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-07-17 15:58
Publish the Manuscript Online	2014-08-07 10:34

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Topic Highlights
Article Title	Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy
Manuscript Source	Invited Manuscript
All Author List	Filippo Ansaldi, Andrea Orsi, Laura Sticchi, Bianca Bruzzone and Giancarlo Icardi
Funding Agency and Grant Number
Corresponding Author	Filippo Ansaldi, MD, Associate Professor, Department of Health Sciences, University of Genoa, Via Antonio Pastore 1, 16132 Genoa, Italy. filippo.ansaldi@unige.it
Key Words	Hepatitis C virus epidemiology; Hepatitis C virus diagnosis; Hepatitis C virus vaccine; Direct-acting antivirals; Predictors of response to hepatitis C virus therapy
Core Tip	Challenges and opportunities will characterise the story of hepatitis C virus (HCV) infection also in the new era. Despite the great therapeutic advances, improvements in HCV surveillance, epidemiological mapping, testing, prevention and therapy are urgently needed. Currently HCV vaccine candidates have shown promising results in animal models and data from clinical phase 1/2 trials are expected. Predictors of response to therapy represent a chance for modulated and personalized treatment management, when also very potent therapies will be available. The ultimate goal of global HCV control will be achieved with the joint efforts of researchers and public health workers.
Publish Date	2014-08-07 10:34
Citation	Ansaldi F, Orsi A, Sticchi L, Bruzzone B, Icardi G. Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy. World J Gastroenterol 2014; 20(29): 9633-9652
URL	http://www.wjgnet.com/1007-9327/full/v20/i29/9633.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i29.9633

Full Article (PDF)	WJG-20-9633.pdf
Full Article (Word)	WJG-20-9633.doc
Manuscript File	7207-Review.docx
Answering Reviewers	7207-Answering reviewers.pdf
Copyright License Agreement	7207-Copyright assignment.pdf
Peer-review Report	7207-Peer review.pdf
Scientific Editor Work List	7207-Scientific editor work list.pdf